Purpose

The primary aim of the study is to determine the amount of newly formed vital bone, residual graft material, and "connective tissue/other" 18 to 20 weeks after ridge preservation is performed using DFDBA fibers alone, DFDBA particulate alone, a combination of xenograft and DFDBA particulate, or a combination of xenograft and DFDBA fibers.

Conditions

Eligibility

Eligible Ages
Over 18 Years
Eligible Genders
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • One tooth, excluding molars, that has been identified by dental faculty as requiring a single tooth extraction - A dental implant is indicated and treatment planned to replace the missing tooth - Have adequate restorative space for a dental implant-retained restoration - Have at least 10mm of alveolar bone height, without impinging on the maxillary sinus or inferior alveolar canal. - Have a dehiscence of the buccal or lingual bony plate of the tooth socket extending no more than 50% of the total depth of the socket. - Female patients who have undergone a hysterectomy, tubal ligation, or menopause, and non-pregnant women of child-bearing potential. - Are nonsmokers or former smokers. Current smokers may be included if they smoke <10 cigarettes per day

Exclusion Criteria

  • Will not cooperate with the follow-up schedule. - Patients will not be entered who are mentally incompetent, prisoners, or pregnant. - Pregnant women or women intending to become pregnant during the study period (as confirmed verbally; an over the counter pregnancy test will be provided if pregnancy status is unknown or suspected). - Patients who become pregnant during the study will be withdrawn and standard care will be delivered. - Smokers who smoke >10 cigarettes per day - Clinical and/or radiographic determinations which will preclude inclusion in this study are: Active infection other than periodontitis; Inadequate bone dimensions or restorative space for a dental implant; Presence of a disease entity, condition or therapeutic regimen which decreases probability of soft tissue and bony healing, e.g., poorly controlled diabetes, chemotherapeutic and immunosuppressive agents, autoimmune diseases, history of bisphosphonate use or long-term steroid therapy; Positive medical history of endocarditis following oral or dental surgery.

Study Design

Phase
N/A
Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel Assignment
Intervention Model Description
4 arm randomized controlled parallel study
Primary Purpose
Treatment
Masking
Single (Outcomes Assessor)
Masking Description
Since the outcome of the study is the histologic healing, blinding of the surgeon is not necessary. Blinding is performed only for histomorphometric measurements. The person doing histomorphometric analysis is blinded as to study group.

Arm Groups

ArmDescriptionAssigned Intervention
Active Comparator
Group 1 Vallos
Subjects will be randomized into one of the four groups and receive the corresponding material for ridge preservation following tooth extraction.
  • Device: Vallos
    Demineralized freeze-dried bone allograft (DFBA) in a small particle form
    Other names:
    • DFDBA particulate
Active Comparator
Group 2 Vallomix
Subjects will be randomized into one of the four groups and receive the corresponding material for ridge preservation following tooth extraction.
  • Device: Vallomix
    A combination of cow-derived xenograft and human-derived DFDBA particulate
    Other names:
    • Xenograft and human-derived DFDBA
Active Comparator
Group 3 Vallos-F
Subjects will be randomized into one of the four groups and receive the corresponding material for ridge preservation following tooth extraction.
  • Device: Vallos-F
    Demineralized freeze-dried bone allograft (DFDBA) in a fiber form
    Other names:
    • DFDBA in fiber form
Active Comparator
Group 4 Vallomix-F
Subjects will be randomized into one of the four groups and receive the corresponding material for ridge preservation following tooth extraction.
  • Device: Vallomix-F
    A combination of cow-derived xenograft and human-derived DFDBA fibers
    Other names:
    • Xenograft (Bio-Oss) combined with DFDBA fibers

Recruiting Locations

University of Texas Health Science Center at San Antonio (Dental School)
San Antonio, Texas 78229
Contact:
Brian L Mealey, DDS, MS
210-567-3589
mealey@uthscsa.edu

More Details

Status
Recruiting
Sponsor
The University of Texas Health Science Center at San Antonio

Study Contact

Brian Mealey, DDS, MS
210-567-3589
mealey@uthscsa.edu

Detailed Description

The study plan is to extract non-molar teeth and graft with the various graft materials. Each subject will provide a single non-molar tooth site for study treatment. Following approx. 18-20 weeks of healing, the study team will harvest a core biopsy at the time of implant placement. The implant osteotomy is prepared with a trephine drill and the core inside the trephine is placed in 10% formalin for future processing and histomorphometric analysis. The core biopsy will be evaluated for the primary histologic outcome of % vital bone formation and the secondary histologic outcomes of % residual graft material, and % "CT/other" (fibrous tissue and marrow space). The study team will also evaluate the following secondary clinical outcomes using a custom measuring stent for each subject: change in ridge width; change in buccal ridge height and change in lingual ridge height. During the 18 to 20-week healing period, patients will be followed as needed per standard care to evaluate healing.

Notice

Study information shown on this site is derived from ClinicalTrials.gov (a public registry operated by the National Institutes of Health). The listing of studies provided is not certain to be all studies for which you might be eligible. Furthermore, study eligibility requirements can be difficult to understand and may change over time, so it is wise to speak with your medical care provider and individual research study teams when making decisions related to participation.